Document:

Exhibit
10.91 

 

Form
of Warrant

 

NEITHER
THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

CARBONMETA
TECHNOLOGIES, INC.

 

Warrant
Shares: 19,125,000

Date
of Issuance: March 28, 2022 (“Issuance Date”)

 

This
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for services provided according to Fee Agreement dated February
23, 2022, J.H. Darbie & Co., Inc., a New York corporation (including any permitted and registered assigns, the “Holder”),
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the
Exercise Period (as defined below), to purchase from CarbonMeta Technologies, Inc., a Delaware corporation (the “Company”),
up to 19,125,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from
time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued
by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 28, 2022, by and among
the Company and the Introduced Party (as defined in the Fee Agreement).

 

Terms
used in this Warrant shall have the meanings set forth in Section 13 below. For purposes of this Warrant, the term “Exercise Price”
shall mean $0.0004, subject to adjustment as provided herein (including but not limited to cashless exercise), and the term “Exercise
Period” shall mean the period commencing on the Issuance Date and ending on 5:00 p.m. eastern standard time on the date which is
5 years after the Issuance Date.

 

1.
EXERCISE OF WARRANT.

 

(a)
Mechanics of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto as Exhibit
B (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder shall not be required to deliver
the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. On or before the second Trading Day (the
“Warrant Share Delivery Date”) following the date on which the Holder sent the Exercise Notice to the Company or the Company’s
transfer agent, and upon receipt by the Company of payment to the Company of an amount equal to the applicable Exercise Price multiplied
by the number of Warrant Shares as to which all or a portion of this Warrant is being exercised (the “Aggregate Exercise Price”
and together with the Exercise Notice, the “Exercise Delivery Documents”) in cash or by wire transfer of immediately available
funds (or by cashless exercise, in which case there shall be no Aggregate Exercise Price provided), the Company shall (or direct its
transfer agent to) issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered
in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise (or deliver such shares of Common Stock in electronic format if requested by the Holder).
Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of
record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates
evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant Shares represented
by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise, then the Company
shall as soon as practicable and in no event later than three Business Days after any exercise and at its own expense, issue a new Warrant
(in accordance with Section 6) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such
exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised.

 

    	1

     

    

 

If
the Company fails to cause its transfer agent to transmit to the Holder the respective shares of Common Stock by the respective Warrant
Share Delivery Date, then the Holder shall have, in addition to all other rights and remedies at law or otherwise, the right to rescind
such exercise in Holder’s sole discretion, and such failure shall be deemed an event of default under the Note.

 

If
the Market Price of one share of Common Stock is greater than the Exercise Price, the Holder may elect to receive Warrant Shares pursuant
to a cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or of
any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which event the Company shall issue
to Holder a number of Common Stock computed using the following formula:

 

X
= Y (A-B)

A

 

	Where	X =	the number of Shares to be issued
  to Holder.
	 		 
	 	Y =	the number of Warrant Shares that the Holder
  elects to purchase under this Warrant (at the date of such calculation).
	 	 	 
	 	A =	the Market Price (at the date of such calculation).
	 	 	 
	 	B =	Exercise Price (as adjusted to the date of
  such calculation).

 

(b)
No Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance
of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction
a sum in cash equal to the product resulting from multiplying the then-current fair market value of a Warrant Share by such fraction.

 

(c)
Holder’s Exercise Limitations. Notwithstanding anything to the contrary contained herein, the Company shall not effect any
exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 1 or otherwise,
to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder
(together with the Holder’s affiliates (the “Affiliates”), and any other Persons acting as a group together with the
Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of
the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of
this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would
be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in
the preceding sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Holder is solely
responsible for any schedules required to be filed in accordance therewith. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 1(c), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission,
as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding at the time of the respective calculation hereunder. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.

 

    	2

     

    

 

2.
ADJUSTMENTS. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)
Distribution of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation any distribution
of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or
other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case:

 

(i)
any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of
shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date,
to a price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing Sale Price of
the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined
in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator of which shall
be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

(ii)
the number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately
prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive
the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding clause (i); provided, however, that
in the event that the Distribution is of shares of common stock of a company (other than the Company) whose common stock is traded on
a national securities exchange or a national automated quotation system (“Other Shares of Common Stock”), then the Holder
may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the terms
of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the number of shares of Other
Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had the Holder exercised this Warrant
immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise price
of this Warrant was decreased with respect to the Distribution pursuant to the terms of the immediately preceding clause (i) and the
number of Warrant Shares calculated in accordance with the first part of this clause (ii).

 

(b)
Anti-Dilution Adjustments to Exercise Price. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant
is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or
announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or securities entitling any person or
entity to acquire shares of Common Stock (upon conversion, exercise or otherwise) (including but not limited to the price at which Common
Stock is issuable under the Note), at an effective price per share less than the then Exercise Price (such lower price, the “Base
Share Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock
Equivalents so issued shall at any time, whether by operation of purchase price adjustments, elimination of an applicable floor price
for any reason in the future (including but not limited to the passage of time or satisfaction of certain condition(s)), reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled or potentially entitled to receive shares of Common Stock at an effective price per share which is less
than the Exercise Price at any time while such Common Stock or Common Stock Equivalents are in existence, such issuance shall be deemed
to have occurred for less than the Exercise Price on such date of the Dilutive Issuance (regardless of whether the Common Stock or Common
Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted
or exercised at such Base Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal
the Base Share Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued, regardless of
whether the Common Stock or Common Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive
Issuance or (ii) actually converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder
may utilize the Base Share Price even if the Company did not actually issue shares of its common stock at the Base Share Price under
the respective Common stock Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day following the
issuance of any Common Stock or Common Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price,
or applicable reset price, exchange price, conversion price and other pricing terms (such notice the “Dilutive Issuance Notice”).
For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b), upon the
occurrence of any Dilutive Issuance, after the date of such Dilutive Issuance the Holder is entitled to the Base Share Price regardless
of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise.

 

    	3

     

    

 

Subdivision
or Combination of Common Stock. If the Company at any time on or after the Issuance Date subdivides (by any stock split, stock dividend,
recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise
Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately
increased. If the Company at any time on or after the Issuance Date combines (by combination, reverse stock split or otherwise) one or
more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior
to such combination will be proportionately increased and the number of Warrant Shares will
be proportionately decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on the date the
subdivision or combination becomes effective. Each such adjustment of the Exercise Price shall be
calculated to the nearest one-hundredth of a cent. Such adjustment shall be made successively whenever any event covered by this
Section 2(c) shall occur.

 

3.
FUNDAMENTAL TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the Company
with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor Entity”),
(ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant
to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property
and the holders of at least 50% of the Common Stock accept such offer, or (iv) the Company effects any reclassification of the Common
Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock) (in any such case, a “Fundamental
Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive the number of shares
of Common Stock of the Successor Entity or of the Company and any additional consideration (the “Alternate Consideration”)
receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event (disregarding any limitation
on exercise contained herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor Entity in such Fundamental Transaction
shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise
such warrant into Alternate Consideration.

 

4.
NON-CIRCUMVENTION. The Company covenants and agrees that it will not, by amendment of its certificate of incorporation, bylaws
or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at
all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of
the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock
upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant is outstanding, have authorized and reserved, free from
preemptive rights, one and a half (1.5) times the number of shares of Common Stock into which the Warrants are then exercisable into
to provide for the exercise of the rights represented by this Warrant (without regard to any limitations on exercise).

 

5.
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself, shall
not entitle the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

    	4

     

    

 

6.
REISSUANCE.

 

(a)
Lost, Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms as
to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

 

(b)
Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new Warrant which
is the same as the Issuance Date.

 

7.
TRANSFER. This Warrant shall be binding upon the Company and its successors and assigns and shall inure to be the benefit of the
Holder and its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations of the Company
hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the prior signed written
consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment or transfer shall be null
and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant or any of the severable rights
and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned by Holder to a third party, in whole
or in part, without the need to obtain the Company’s consent thereto.

 

8.
NOTICES. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with prompt written
notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation of such adjustment
and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend
or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of any stock or other securities
directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock or other property, pro rata to the
holders of shares of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation,
provided in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided
to the Holder.

 

9.
AMENDMENT AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company and the Holder.

 

10.
GOVERNING LAW AND VENUE. This Warrant shall be governed by and construed in accordance with the laws of the State of Nevada without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Warrant shall be brought only in the state courts located in the Commonwealth of Massachusetts or federal courts located in Commonwealth
of Massachusetts. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT ENTERED INTO IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION
DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. The prevailing party shall
be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Warrant
or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with
such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity
or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents
to process being served in any suit, action or proceeding in connection with this Agreement
or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law.

 

    	5

     

    

 

11.
PIGGYBACK REGISTRATION RIGHTS. The Company hereby grants to the Buyer the registration rights set forth on Exhibit D hereto.

 

12.
ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained herein.

 

13.
CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)
“Nasdaq” means www.Nasdaq.com.

 

(b)
“Closing Sale Price” means, for any security as of any date, (i) the last closing trade price for such security on
the Principal Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does not designate
the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported by Nasdaq, or (ii)
if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such security as reported by
Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid and ask prices of any market
makers for such security as reported by the OTC Markets. If the Closing Sale Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined
by the Company and the Holder. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination
or other similar transaction during the applicable calculation period.

 

(c)
“Common Stock” means the Company’s common stock, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

(d)
“Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at
any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

(e)
[Intentionally Omitted].

 

(f)
“Person” and “Persons” means an individual, a limited liability company, a partnership, a joint venture,
a corporation, a trust, an unincorporated organization, any other entity and any governmental entity or any department or agency thereof.

 

(g)
“Principal Market” means the primary national securities exchange on which the Common Stock is then traded.

 

(h)
“Market Price” means the highest traded price of the Common Stock during the one hundred fifty Trading Days prior
to the date of the respective Exercise Notice.

 

(i)
“Trading Day” means (i) any day on which the Common Stock is listed or quoted and traded on its Principal Market,
(ii) if the Common Stock is not then listed or quoted and traded on any national securities exchange, then a day on which trading occurs
on any over-the-counter markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.

 

*
* * * * * *

 

    	6

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

 

	 	CarbonMeta
  Technologies, Inc.
	 	 	 
	 	By:	 
	 	Name:	Lloyd Spencer
	 	Title:	CEO

 

    	7

     

    

 

EXHIBIT
B

 

NOTICE
OF EXERCISE

 

(To
be executed by the registered holder to exercise this Common Stock Purchase Warrant)

 

THE
UNDERSIGNED holder hereby exercises the right to purchase of the shares of Common Stock (“Warrant Shares”) of CarbonMeta
Technologies, Inc., a Delaware corporation (the “Company”), evidenced by the attached copy of the Common Stock Purchase Warrant
(the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in
the Warrant.

 

1.
Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as (check one):

 

☐
a cash exercise with respect to Warrant Shares; or

 

☐
by cashless exercise pursuant to the Warrant.

 

2.
Payment of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable Aggregate Exercise Price in
the sum of $___________ to the Company in accordance with the terms of the Warrant.

 

3. Delivery
of Warrant Shares. The Company shall deliver to the holder ____________ Warrant Shares in accordance with the terms of the
Warrant.

 

Date:____________________

 

	 	 
	 	(Print Name of
  Registered Holder)

 

	 	By:	 
	 	Name:	
	 	Title:	

 

    	8

     

    

 

EXHIBIT
C

 

ASSIGNMENT
OF WARRANT

 

(To
be signed only upon authorized transfer of the Warrant)

 

FOR
VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers unto the right to purchase____________________
shares of common stock of CarbonMeta Technologies, Inc., to which
the within Common Stock Purchase Warrant relates and appoints__________________ , as attorney-in-fact, to transfer said right on the
books of CarbonMeta Technologies, Inc. with full power of substitution and re- substitution in the premises. By accepting such transfer,
the transferee has agreed to be bound in all respects by the terms and conditions of the within Warrant.

 

Dated:____________________

 

	 	 
	 	(Signature)
	 	 
	 	 
	 	(Name)
	 	 
	 	
	 	(Address)
	 	 
	 	 
	 	(Social
  Security or Tax Identification No.)

 

*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase Warrant
in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation, partnership,
trust, or other entity, please indicate your position(s) and title(s) with such entity.

 

    	9

     

    

 

EXHIBIT
D

 

REGISTRATION
RIGHTS

 

All
of the shares into which the Warrant is exercisable into will be deemed “Registrable Securities” subject to the provisions
of this Exhibit C.

 

1.
Piggy-Back Registration.

 

1.1
Piggy-Back Rights. If at any time on or after the date of the Closing the Company proposes to file any Registration Statement under the
1933 Act (a “Registration Statement”) with respect to any offering of equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for shareholders of the
Company for their account (or by the Company and by shareholders of the Company), other than a Registration Statement (i) filed in connection
with any employee stock option or other benefit plan on Form S-8, (ii) for a dividend reinvestment plan or (iii) in connection with a
merger or acquisition, then the Company shall (x) give written notice of such proposed filing to the holders of Registrable Securities
appearing on the books and records of the Company as such a holder as soon as practicable but in no event less than ten (10) days before
the anticipated filing date of the Registration Statement, which notice shall describe the amount and type of securities to be included
in such Registration Statement, the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters,
if any, of the offering, and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of
such number of Registrable Securities as such holders may request in writing within three (3) days following receipt of such notice (a
“Piggy-Back Registration”). The Company shall cause such Registrable Securities to be included in such registration and shall
cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Registrable Securities requested to
be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Company and to permit the
sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All holders
of Registrable Securities proposing to distribute their securities through a Piggy- Back Registration that involves an underwriter or
underwriters shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggy-Back
Registration.

 

1.2
Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of Registrable Securities
in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the
Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a demand pursuant
to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration
Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders of Registrable Securities
in connection with such Piggy-Back Registration as provided in Section

1.5
below.

 

1.3
The Company shall notify the holders of Registrable Securities at any time when a prospectus relating to such holder’s Registrable
Securities is required to be delivered under the 1933 Act, upon discovery that, or upon the happening of any event as a result of which,
the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances
then existing. At the request of such holder, the Company shall also prepare, file and furnish to such holder a reasonable number of
copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of
the Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing.
The holders of Registrable Securities shall not to offer or sell any Registrable Securities covered by the Registration Statement after
receipt of such notification until the receipt of such supplement or amendment.

 

    	10

     

    

 

1.4
The Company may request a holder of Registrable Securities to furnish the Company such information with respect to such holder and such
holder’s proposed distribution of the Registrable Securities pursuant to the Registration Statement as the Company may from time
to time reasonably request in writing or as shall be required by law or by the SEC in connection therewith, and such holders shall furnish
the Company with such information.

 

1.5
All fees and expenses incident to the performance of or compliance with this Exhibit D by the Company shall be borne by the Company whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence
shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company’s
counsel and independent registered public accountants) (A) with respect to filings made with the SEC, (B) with respect to filings required
to be made with any trading market on which the Common Stock is then listed for trading, (C) in compliance with applicable state securities
or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for
the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities) and (D) with respect to any filing
that may be required to be made by any broker through which a holder of Registrable Securities intends to make sales of Registrable Securities
with the FINRA, (ii) printing expenses, (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for
the Company, (v) 1933 Act liability insurance, if the Company so desires such insurance, (vi) fees and expenses of all other persons
or entities retained by the Company in connection with the consummation of the transactions contemplated by this Exhibit D and (vii)
reasonable fees and disbursements of a single special counsel for the holders of Registrable Securities (selected by holders of the majority
of the Registrable Securities requesting such registration). In addition, the Company shall be responsible for all of its internal expenses
incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries
and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall
the Company be responsible for any broker or similar commissions of any holder of Registrable Securities.

 

1.6
The Company and its successors and assigns shall indemnify and hold harmless the Buyer, each holder of Registrable Securities, the officers,
directors, members, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person
holding such titles, notwithstanding a lack of such title or any other title) of each of them, each individual or entity who controls
the Buyer or any such holder of Registrable Securities (within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act)
and the officers, directors, members, stockholders, partners, agents and employees (and any other individuals or entities with a functionally
equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling individual
or entity (each, an “Indemnified Party”), to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained
in a Registration Statement, any related prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any such prospectus or supplement thereto, in light of the circumstances under which they
were made) not misleading or (2) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act or any state securities
law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Exhibit D, except to the
extent, but only to the extent, that (i) such untrue statements or omissions are based upon information regarding the Buyer or such holder
of Registrable Securities furnished to the Company by such party for use therein. The Company shall notify the Buyer and each holder
of Registrable Securities promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions
contemplated by this Exhibit D of which the Company is aware.

 

1.7
If the indemnification under Section 1.6 is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless
for any Losses, then the Company shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate
to reflect the relative fault of the Company and Indemnified Party in connection with the actions, statements or omissions that resulted
in such Losses as well as any other relevant equitable considerations. The relative fault of the Company and Indemnified Party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of
a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by,
the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include
any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in Section 1.6 was available to such
party in accordance with its terms. It is agreed that it would not be just and equitable if contribution pursuant to this Section 1.7
were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the immediately preceding sentence. Notwithstanding the provisions of this Section 1.7, neither the Buyer nor any holder
of Registrable Securities shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds
actually received by such party from the sale of all of their Registrable Securities pursuant to such Registration Statement or related
prospectus exceeds the amount of any damages that such party has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission.

 

[End
of Exhibit D]

 

    	11Exhibit
10.92

 

 

CarbonMeta
Technologies, Inc.

13110
NE 177th Place

#145

Woodinville,
WA 98072

 

	 	Re:	Proposed
    Private Placement Financing

 

Dear
Lloyd Spencer

 

This
letter will confirm the understanding and agreement (the “Agreement”) between J H Darbie & Co., Inc. (“Darbie”),
and CarbonMeta Technologies, Inc. (the “Company”), as follows:

 

1.
Engagement. The Company hereby engages Darbie on a nonexclusive basis (becoming a 180 month exclusive, commencing upon closing
the first funding tranche), to conduct a review of the business and financial condition of the Company and its proposed Private Placement
financing (“Offering”) to be used in connection with the Offering, with a view toward possibly participating as a
sales agent in the private placement of one or more Convertible Notes and an Equity Line of Credit (“ELOC”) (the “Securities”)
of the Company to a limited number of investors (“Investors”) to be introduced to the Company by Darbie and other
authorized securities broker-dealers that are members in good standing of The Financial Industry Regulatory Authority, Inc. (“FINRA”).
Such private placement will be referred to as the “Transaction.” Currently, the Company plans to raise up to $500,000
through one or more Convertible Notes and $5,000,000 through an ELOC. The number and price of the Securities the Company will ultimately
agree to sell and the Investors to whom the Securities are sold, pursuant to the Subscription Documents (defined below), are entirely
within the Company’s discretion.

 

2.
Offering Materials. The Company will prepare and deliver to Darbie copies of subscription materials including the appropriate
disclosure documents, relating to, among other things, the Company, the Securities, and the terms of the Offering. These subscription
materials, including all exhibits thereto and all documents delivered therewith and incorporated by reference therein, are referred to
herein as the “Offering Materials,” unless the subscription material (including exhibits or documents) is supplemented
or amended in accordance with this Agreement, in which event, the term “Offering Materials” refers to such subscription
material, exhibits, and documents as so supplemented or amended from and after the time of its delivery to Darbie. The Company is responsible
for reviewing and finally approving the Offering Materials and all related documents used by Darbie in the Transaction.

 

(a)
Darbie’s Role. Darbie hereby accepts the engagement described herein and, in that connection, agrees to assist and advise
the Company respecting the terms of the Transaction.

 

3.
Due Diligence. It is understood that Darbie’s assistance in the Transaction will be subject to the completion, satisfactory
to Darbie in its sole discretion, of its Due Diligence and the approval of Darbie’s supervisory personnel of the undertaking. Darbie
will have the right, in its sole discretion, to terminate this Agreement if the outcome of the Due Diligence is not satisfactory to Darbie
or if approval of its supervisory personnel is not obtained (“Early Termination”).

 

J.H.
Darbie & Co.

40
Wall Street New York, NY 10005

Telephone:
212-269-7271 Fax: 212-269-7330

www.jhdarbie.com

 

    	 

    	 

    

 

J.
H. DARBIE & CO., INC.

 

CarbonMeta
Technologies, Inc.

February
23, 2022

Page
2

 

4.
Term.

 

(a)
The term of Darbie’s engagement hereunder will extend from the date hereof until: (i) Early Termination; (ii) 60 days from the
date of this agreement; (iii) all offered Securities are sold; (iv) the Offering is terminated by the Company; or (v) this Agreement
is terminated by either party as provided below, whichever first occurs.

 

(b)
During the term of Darbie’s engagement hereunder: (i) the Company will have the right to contact or solicit institutions, corporations,
or other entities as potential purchasers of the Securities; and (ii) The Company may reject a potential Investor if, in its discretion,
the Company believes that the inclusion of such Investor in the Company would be incompatible with the Company’s best interests.
The Company will not be obligated to sell the Securities or to accept any offer therefor, and the terms of the Securities and the final
decision to issue the same will be subject to the Company’s discretionary approval.

 

(c)
Either party may terminate this Agreement at any time by giving the other party at least 15 days’ prior written notice of such
termination. Termination will not alter the Company’s obligation to pay Darbie’s fees in accordance with section 8. Any obligation
pursuant to this section 4 will survive the termination or expiration of this Agreement. No offers or sales of any securities of the
same or similar class as the Securities will be made by the Company or any affiliate during the 60-month period after the completion
of the Offering.

 

(d)
If during the Term of this Agreement and for the 24 months following termination or expiration of this Agreement, an Investor purchases
equity or debt securities from the Company; the Company will pay Darbie fee in the amount that would otherwise have been payable to Darbie
in accordance with this Agreement had such Transaction occurred during the Term. The fee will be payable upon the receipt of the purchase
price for the securities or the close of the Transaction,

 

5.
Best Efforts. Subject to the satisfactory completion of its Due Diligence and election to participate in the Transaction, the
Company acknowledges that Darbie’s involvement in the Transaction is strictly on a “best-efforts” basis and that the
consummation of the Transaction will be subject to, among other things, market conditions.

 

6.
Information. The Company will furnish, or cause to be furnished, to Darbie all information reasonably requested by Darbie and
its counsel for the purpose of rendering services hereunder (all such information being the “Information”). In addition,
the Company agrees to make available to Darbie and its counsel upon request, from time to time, the officers, directors, accountants,
counsel, and other advisors of the Company. The Company recognizes and confirms that Darbie and its counsel: (a) will use and rely on
the Information and on information available from generally recognized public sources in performing the services contemplated by this
Agreement without having independently verified the same; (b) do not assume responsibility for the accuracy or completeness of the Information
and such other information; and (c) will not make an appraisal of any of the Company’s assets or liabilities.

    	 

    	 

    

 

J.
H. DARBIE & CO., INC.

 

CarbonMeta
Technologies, Inc.

February
23, 2022

Page
3

 

7.
Company’s Responsibilities, Representations, and Warranties.

 

(a)
The Company represents and warrants to Darbie that: (i) the Offering Materials (excluding any documents attached as exhibits or incorporated
by reference to the Offering Materials) is or will be, as of their respective dates, true and accurate in all material respects and do
not and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
made therein, in light of the circumstances under which they were made, not misleading; and (ii) any projected financial Information
or other forward-looking Information that the Company provides to Darbie will be made by the Company in good faith and based on facts
and assumptions that the Company believes to be reasonable.

 

(b)
The sale of Securities to any Investor will be evidenced by a subscription agreement and related subscription documents, in forms reasonably
satisfactory to the Company and Darbie (collectively, “Subscription Documents”), between the Company and such Investor.
Prior to the signing of any Subscription Documents, officers of the Company with responsibility for financial affairs will be available
to answer inquiries from prospective Investors.

 

(c)
The selling price of the Securities and the number to be issued and sold by the Company pursuant to the Subscription Documents will be
specified in writing by the Company.

 

(d)
The Company will perform the covenants set forth in the Subscription Documents.

 

(e)
The Company: (i) represents and warrants that the representations and warranties contained in the Subscription Documents will be true
and correct in all respects on the date of the Subscription Documents and on the closing date; and (ii) agrees that Darbie will be entitled
to rely on such representations and warranties as if they were made directly to Darbie.

 

(f)
The Company agrees that it will comply with all applicable terms and conditions of the Securities Act of 1933, as amended, to ensure
that the sale of Securities contemplated by this Agreement will be exempt from the registration requirements, and the Company will otherwise
comply with the securities laws of any applicable country or other jurisdiction. The Company will not take any action or permit any action
to be taken on its behalf that would cause the sale of any Securities to fail to qualify for such an exemption or otherwise comply with
applicable securities laws.

 

(g)
The Company warrants and represents that none of its directors, executive officers, other officers participating in the Offering, or
any soliciting associated person of the Company compensated in connection with this Offering (each, a “Covered Person”
and collectively, “Covered Persons”) is subject to any of the “bad actor” disqualifying events described
in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualifying Event”). The Company warrants and represents
that it has exercised reasonable care to determine whether any Covered Person is subject to a Disqualifying Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506 and further agrees to promptly notify Darbie in writing should
any Disqualifying Events come to the attention of the Company during the term of this Agreement that could be reasonably expected to
have a material adverse consequence on the Offering or Darbie’s services provided in connection therewith.

 

(h)
The Company represents and warrants to Darbie that there are no brokers, representatives, or other persons who have an interest in compensation
due to Darbie from any Transaction contemplated herein or who would otherwise be due any fee, commission, or remuneration upon consummation
of any Transaction.

 

    	 

    	 

    

 

J.
H. DARBIE & CO., INC.

 

CarbonMeta
Technologies, Inc.

February
23, 2022

Page
4

 

8.
Fees.

 

(a)
As compensation for the services to be rendered by Darbie hereunder, the Company will pay to Darbie a fee equal to 9% of the gross proceeds
raised from the sale of the Securities to customers of Darbie, including all amounts placed in an escrow account or payable in the future
and all amounts paid or payable upon exercise, conversion or exchange of such securities received or receivable directly by the Company
in any placement of the Company’s securities directly or indirectly resulting from Darbie’s introductions to prospective
investors. Such consideration paid in cash shall be paid directly to Darbie out of escrow, as and when such consideration is paid to
the Company.

 

(b)
As further compensation for the services to be rendered by Darbie hereunder, the Company shall issue to Darbie warrants to purchase that
number of Securities that equals 9% of the number of Securities sold by Darbie in the offering. The warrants shall have the same terms
and exercise price of the warrants purchased by investors in this offering. The warrants shall be exercisable immediately after the date
of issuance, shall have participating registration rights and shall expire 5 years after the date of issuance, unless otherwise extended
by the Company. The warrants shall include a cashless exercise provision and will be non-redeemable and provide for automatic exercise
upon expiration. The warrants shall be transferable, subject only to the securities laws, by the holders thereof.

 

(c)
The Company’s obligations under this section will survive the termination or expiration of this Agreement.

 

9.
Indemnity. In addition to the fees provided for above, the parties agree to the following indemnification provisions:

 

(a)
The Company agrees to indemnify and hold harmless Darbie and its affiliates, and their respective directors, officers, employees, agents,
and controlling persons (each such person, including Darbie, an “Indemnified Party”), from and against any losses,
claims, damages, and liabilities, joint or several (collectively, the “Damages”), to which an Indemnified Party may
become subject in connection with or otherwise relating to or arising from: (i) any Transaction or the engagement of, or performance
of services by, an Indemnified Party hereunder; or (ii) any untrue statement of a material fact or omission to state a material fact
necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading. The Company
agrees to will reimburse each Indemnified Party for all fees and expenses (including the fees and expenses of counsel) (collectively,
“Expenses”) as incurred in connection with investigating, preparing, pursuing, or defending any threatened or pending
claim, action, proceeding, or investigation (collectively, the “Proceedings”) arising therefrom, whether or not the
Indemnified Party is a formal party to such Proceeding; provided, that the Company will not be liable to any Indemnified Party
to the extent that any Damages are found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from
the gross negligence or willful misconduct of the Indemnified Party seeking indemnification hereunder. The Company also agrees that no
Indemnified Party will have any liability (whether direct or indirect, in contract, tort or otherwise) to the Company or any person asserting
claims on the Company’s behalf arising out of or in connection with any Transactions or the engagement of, or performance of services
by, any Indemnified Party thereunder, except to the extent that any Damages are found in a final, non-appealable judgment by a court
of competent jurisdiction to have resulted from the gross negligence or willful misconduct of the Indemnified Party.

 

    	 

    	 

    

 

J.
H. DARBIE & CO., INC.

 

CarbonMeta
Technologies, Inc.

February
23, 2022

Page
5

 

(b)
If for any reason, other than in accordance with this Agreement, the foregoing indemnity is unavailable to an Indemnified Party or insufficient
to hold an Indemnified Party harmless, then the Company will contribute to the amount paid or payable by an Indemnified Party as a result
of Damages (including all Expenses incurred) such proportion as is appropriate to reflect the relative benefits to the Company and its
stockholders, on the one hand, and Darbie, on the other hand, in connection with the matters covered by this Agreement. If the foregoing
allocation is not permitted by applicable law, the Company will contribute to the amount paid or payable by an Indemnified Party as a
result of Damages (including all Expenses incurred) such proportion as is appropriate to reflect not only the relative benefits but also
the relative faults of the parties as well as any relevant equitable considerations. The Company agrees that for purposes of this section,
the relative benefits to the Company and its stockholders and Darbie in connection with the matters covered by this Agreement will be
deemed to be in the same proportion that the total value paid or received or to be paid or received by the Company and its stockholders
in connection with the Transactions, whether or not consummated, bears to the fees paid to Darbie under this Agreement; provided,
that in no event will the total contribution of all Indemnified Parties to all Damages exceed the amount of fees actually received and
retained by Darbie hereunder (excluding any amounts received by Darbie for performing Due Diligence).

 

(c)
The Company agrees not to enter into any waiver, release, or settlement of any Proceedings (whether or not Darbie or any other Indemnified
Party is a formal party to such Proceedings) in respect of which indemnification may be sought hereunder without the prior written consent
of Darbie (which consent will not be unreasonably withheld), unless the waiver, release, or settlement includes an unconditional release
of Darbie and each Indemnified Party from all liability arising out of the Proceeding.

 

(d)
The indemnity, reimbursement, and contribution obligations of the Company hereunder will be in addition to any liability that the Company
may otherwise have to any Indemnified Party and will be binding upon and inure to the benefit of any successors, assigns, heirs, and
personal representatives of the Company or an Indemnified Party.

 

(e)
The provisions of this indemnification section will survive the modification, termination, or expiration of this Agreement.

 

10.
Governing Law. This Agreement will be governed by and construed and interpreted in accordance with the laws of the state of New
York, without giving effect to any choice or conflict of law provision or rule (whether the state of New York or any other jurisdiction)
that would cause the application of the laws of any jurisdiction other than the state of New York. All disputes respecting this Agreement
will be resolved through arbitration.

 

11.
Confidentiality. Except for disclosure to the Investors and as otherwise required by law, this Agreement and the services and
advice to be provided by Darbie hereunder will not be disclosed to third parties without Darbie’s prior written permission. Notwithstanding
the foregoing, Darbie will be permitted to advertise the services it provided in connection with the Transaction subsequent to the consummation
of the Transaction.

 

12.
Compliance by Darbie. Notwithstanding the Company’s obligations in subsection 7(f), Darbie agrees that it will comply with
the applicable terms and conditions of the Securities Act of 1933, as amended, to ensure that the sale of Securities by it contemplated
by this Agreement will be exempt from the registration requirements, and Darbie will otherwise comply with applicable securities laws
in connection with the services it provides pursuant to this Agreement.

 

13.
Authorization. Each of the Company and Darbie represent and warrant that it has all requisite power and authority to enter into
and carry out the terms and provisions of this Agreement and the execution, delivery, and performance of this Agreement does not breach
or conflict with any agreement, document, or instrument to which it is a party or bound.

 

    	 

    	 

    

 

J.
H. DARBIE & CO., INC.

 

CarbonMeta
Technologies, Inc.

February
23, 2022

Page
6

 

14.
Miscellaneous. This Agreement constitutes the entire understanding and agreement between the Company and Darbie respecting the
subject matter hereof and supersedes all prior understandings or agreements between the parties with respect thereto, whether oral or
written, express or implied. Any amendments or modifications must be executed in writing by both parties. This Agreement and all rights,
liabilities, and obligations hereunder will be binding upon and inure to the benefit of each party’s successors, but may not be
assigned without the prior written approval of the other party. This Agreement may be executed in any number of counterparts, each of
which will be deemed to be an original, but all of which will, together, constitute only one instrument. The descriptive headings of
the sections of this Agreement are inserted for convenience only, do not constitute a part of this Agreement, and will not affect in
any way the meaning or interpretation of this Agreement.

 

 

 

Darbie
looks forward to working with you. Please confirm that the foregoing correctly sets forth our agreement by signing the enclosed duplicate
of this letter in the space provided and returning it to us, whereupon this letter will constitute a binding agreement as of the date
first above written.

 

 

 

	J.
    H. DARBIE & CO., INC.
	 	 	 
	By:		 
	Name:	Xavier
    Vicuna	 
	Title:	Vice
    President	 

 

Accepted
and agreed to

as
of the above date:

 

	CarbonMeta
    Technologies, Inc.
	 	 	 
	By:		 
	Name:	Lloyd
    Spencer	 
	Title:	CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]